2019-12-25
Crystalvue goes IPO (6527-TW)
Crystalvue Medical Corporation (6527-TW) goes public!
The initial price was $59.8 per share and has surged to $83.1 on the first day of IPO.
Crystalvue CEO, Dr. William Wang, is optimistic about the growth of the company, mentioning that Crysatlvue products will be sent to China's CFDA in the first quarter of next year for certification, also, Crystalcue has signed a long-term AI development contract with Google, and working on projects with Taiwan ITRI, all of which are driving growth momentum for operations.
Reference:
非凡新聞｜USTV 非凡電視
鉅亨網
The initial price was $59.8 per share and has surged to $83.1 on the first day of IPO.
Crystalvue CEO, Dr. William Wang, is optimistic about the growth of the company, mentioning that Crysatlvue products will be sent to China's CFDA in the first quarter of next year for certification, also, Crystalcue has signed a long-term AI development contract with Google, and working on projects with Taiwan ITRI, all of which are driving growth momentum for operations.
Reference:
非凡新聞｜USTV 非凡電視
鉅亨網